Clinical Trial Update: A Study of DII235 in Adults With Elevated Lipoprotein(a) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating DII235 in adults with elevated lipoprotein(a) to assess safety and preliminary efficacy; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Elevated Lipoprotein
• Hyperlipoproteinemia

Drugs mentioned

• DII235 (DII235)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Lipoprotein Disorder | Phase 2 | Status: RECRUITING